Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (unaudited)

v3.24.3
Statements of Operations (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 2,401,359 $ 902,977 $ 6,011,201 $ 2,934,541
General and administrative 824,294 909,001 3,301,753 2,887,533
Total operating expenses 3,225,653 1,811,978 9,312,954 5,822,074
Loss from operations (3,225,653) (1,811,978) (9,312,954) (5,822,074)
Other income and expenses:        
Interest income, net 52,497 92,767 176,431 161,357
Net loss $ (3,173,156) $ (1,719,211) $ (9,136,523) $ (5,660,717)
Net loss per share of Common Stock, basic and diluted $ (2.04) $ (8.09) $ (10.22) $ (36.91)
Weighted-average basic and diluted Common Stock 1,554,680 212,544 894,168 153,380